<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>728</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15494511</PubmedId>
            <Abstract>Human HLA-B*3501 binds an antigenic peptide of 14-aa length derived from an alternative reading frame of M-CSF with high affinity. Due to its extraordinary length, the exact HLA binding mode was unpredictable. The crystal structure of HLA-B*3501 at 1.5 A shows that the N and C termini of the peptide are embedded in the A and F pockets, respectively, similar to a peptide of normal length. The central part of the 14-meric peptide bulges flexibly out of the groove. Two variants of the alternative reading frame of M-CSF peptide substituted at P2 or P2 and P9 with Ala display weak or no T cell activation. Their structure differs mainly in flexibility and conformation from the agonistic peptide. Moreover, the variants induce subtle changes of MHC alpha-helical regions implicated as critical for TCR contact. The TCR specifically recognizing this peptide/MHC complex exhibits CDR3 length within the normal range, suggesting major conformational adaptations of this receptor upon peptide/MHC binding. Thus, the potential antigenic repertoire recognizable by CTLs is larger than currently thought.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>5610-6</ArticlePages>
            <ArticleTitle>Conformational restraints and flexibility of 14-meric peptides in complex with HLA-B*3501.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Probst-Kepper</LastName>
                    <ForeName>Michael</ForeName>
                </Author>
                <Author>
                    <LastName>Hecht</LastName>
                    <ForeName>Hans-Jürgen</ForeName>
                </Author>
                <Author>
                    <LastName>Herrmann</LastName>
                    <ForeName>Hanne</ForeName>
                </Author>
                <Author>
                    <LastName>Janke</LastName>
                    <ForeName>Viktoria</ForeName>
                </Author>
                <Author>
                    <LastName>Ocklenburg</LastName>
                    <ForeName>Frank</ForeName>
                </Author>
                <Author>
                    <LastName>Klempnauer</LastName>
                    <ForeName>Jürgen</ForeName>
                </Author>
                <Author>
                    <LastName>van den Eynde</LastName>
                    <ForeName>Benoit J</ForeName>
                </Author>
                <Author>
                    <LastName>Weiss</LastName>
                    <ForeName>Siegfried</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany. probst-kepper.michael@mh-hannover.de.</Affiliations>
            <ArticleChemicalList>HLA-B35 Antigen;Macromolecular Substances;Peptide Fragments;Receptors, Antigen, T-Cell, alpha-beta;Macrophage Colony-Stimulating Factor;Alanine</ArticleChemicalList>
            <ArticleMeshHeadingsList>Alanine(chemistry); Amino Acid Sequence; Amino Acid Substitution(immunology); Antigen Presentation; Clone Cells; Crystallography, X-Ray; HLA-B35 Antigen(chemistry; immunology; metabolism); Humans; Macromolecular Substances; Macrophage Colony-Stimulating Factor(chemistry; immunology; metabolism); Molecular Sequence Data; Peptide Fragments(chemistry; immunology; metabolism); Protein Binding(immunology); Protein Conformation; Protein Structure, Secondary; Receptors, Antigen, T-Cell, alpha-beta(chemistry; metabolism); T-Lymphocytes, Cytotoxic(immunology; metabolism)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>173</Volume>
                <Issue>9</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>human M-CSF Alternative reading frame peptide (alt.M-CSF)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LPAVVGLSPGEQEY</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC264985</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Text P. 5612</LocationOfData>
                <EpitopeId>38421</EpitopeId>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This peptide was discovered as derived from a tumor-associated Ag, recognized by a tumor-infiltrating CD8 T cell clone. This CTL clone was shown to recognize this antigenic peptide from alternative reading frame of the human M-CSF (alt.M-CSF)4, and presented by HLA-B*3501. Epitope is encoded by DNA sequence 27262660 (GenBank ID) positions 240-281, which are part of an alternate reading frame of the gene coding for human M-CSF.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Tables I, II, Figure 1 and PDB 1XH3</LocationOfData>
                        <MhcBindingId>7225</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>175</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1.48</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>195</MhcAlleleId>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1XH3</ComplexPdbId>
                            <MhcChain1PdbChain>A</MhcChain1PdbChain>
                            <MhcChain2PdbChain>B</MhcChain2PdbChain>
                            <EpitopePdbChain>C</EpitopePdbChain>
                            <EpitopeResidues>C: L1, P2, A3, V4, V5, G6, L7, S8, P9, G10, E11, Q12, E13, Y14</EpitopeResidues>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>The MHC interacting residues and peptide-MHC contacts are not provided in the paper. The overall structure of HLA-B*3501 in complex with alt.M-CSF peptide shows standard MHC fold and does not differ significantly from other structures of HLA-B*3501 in complexes with an octamer Nef peptide (PDB ID 1a1n) and a nonamer EBV nuclear Ag (Ebna)3C peptide (PDB ID 1a9e).</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>C: L1, P2, A3, V4, V5, G6, L7, S8, P9, G10, E11, Q12, E13, Y14</EpitopeResidues>
                                <EpitopeResiduesInteractingWithMhc>C: ;</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: ;</MhcResiduesInteractingWithEpitope>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResiduesInteractingWithMhc>C: L1, P2, A3, V4, V5, G6, P9, E11, Q12, E13, Y14</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: M5, Y7, Y9, Y59, R62, N63, I66, F67, T69, N70, T73, Y74, E76, S77, N80, L81, Y84, I95, R97, Y99, S116, Y123, T143, K146, W147, A150, V152, Q155, L156, Y159, W167, Y171</MhcResiduesInteractingWithEpitope>
                                <ContactAreaForEpitope>1089.4</ContactAreaForEpitope>
                                <ContactAreaForMhc>764.5</ContactAreaForMhc>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

